FDA Announces Joint Meeting of Psychopharmacologic and Peripheral/Central Nervous System Drugs Advisory Committees

Summary

The FDA is hosting a joint meeting of its Psychopharmacologic Drugs Advisory Committee and Peripheral and Central Nervous System Drugs Advisory Committee to provide public advice on regulatory issues, with a public docket and comment period to follow.